EGRX

Eagle Pharmaceuticals, Inc.

Delisted

EGRX was delisted on the 2nd of October, 2024.

146 hedge funds and large institutions have $515M invested in Eagle Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 55 increasing their positions, 53 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$11.8M
2 +$9.73M
3 +$6.28M
4
Wells Fargo
Wells Fargo
California
+$5.16M
5
BlackRock
BlackRock
New York
+$4.31M

Top Sellers

1 -$18.8M
2 -$8.01M
3 -$5.31M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$3.62M
5
Norges Bank
Norges Bank
Norway
-$3.55M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$89.1M
2
$65.5M
3
$32.2M
4
$31.6M
5
$30.7M
6
$14.8M
7
$13.6M
8
$12.9M
9
$11.9M
10
$11.2M
11
$8.62M
12
$8.46M
13
$8.43M
14
$8.36M
15
$7.59M
16
$7.57M
17
$7.44M
18
$7.36M
19
$7.19M
20
$6.55M
21
$6.46M
22
$6.42M
23
$5.9M
24
$5.35M
25
$5.25M